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Abstract: Nitrile oxides were generated by the catalytic dehydrogenation of aromatic aldehyde oximes 2a-g 
with chloramine-T as oxidizing agent. The 1,3-dipolar cycloaddition of in situ generated nitrile oxides with 
ethyl oleate 1 produced a series of new ethyl 8-(3-aryl-4-octyl-4,5-dihydroisoxazol-5-yl)octanoate 3a-g in 65-
84% yield. Some of the synthesized cycloadducts have exhibited moderate to good antifungal and antibacterial 
activity.  





Five membered heterocycle such as isoxazolines are considered as useful intermediates in organic 
synthesis, they serve as building blocks for the construction of various biologically active molecules.1 
Isoxazoline and their derivatives are known to exhibit enormous biological applications such as hypoglycemic, 
analgesic, anti-inflammatory and HIV-inhibitory activity,2 also found to exhibit antimicrobial,3 potent selective 
agonists at human cloned dopamine D4 receptors.4 GABAA antagonist,5 COX-2 inhibitory,6 antioxidant,7 
anticancer,8 and antibiotic, antitumour, insecticidal, tubercular, antinociceptive activities.1-2  
 The most convenient synthesis of isoxazoline and isoxazole ring system has been executed in the 
literature via 1, 3-dipolar cycloaddition reactions of alkenes and alkynes with nitrile oxides generated in situ 
from aldoximes.9-10 Chloramine-T is considered as useful reagent in organic synthesis, particularly in the 
synthesis of biologically active heterocycles.11-12 In view of broad spectrum of synthetic and biological 
applications of isoxazolines, and in search of efficient antimicrobial agents, this project was undertaken. Here in 
we report the use of biomolecule ethyl oleate as dipolarophile moiety in 1, 3-dipolar cycloaddition reactions in 
the synthesis of new isoxazolines and their biological evaluation for antibacterial and antioxidant activity. 
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Materials and Methods 
The chemicals/reagents used were purchased from sigma-aldrich chemicals (India) and Merck Chemicals 
(India). The 1H NMR were recorded on a Bruker supercon 400 MHz spectrophotometer using CDCl3 as solvent 
and TMS as an internal standard. The Chemical shifts are expressed in  ppm. Mass spectra were obtained on 
Shimadzu LCMS-2010A spectrophotometer (positive chemical ionization) and the important fragments are 
given with the relative intensities in the bracket. Elemental analysis was obtained on a Thermo Finnigan Flash 
EA 1112 CHN analyzer. Chromatographic separations were carried out on silica gel (70-230 mesh, Merck) 
column using hexane: ethyl acetate (8:1) as eluent.  
In a general 1,3-dipolar cycloaddition reaction, a mixture of ethyl oleate 1, aromatic aldoximes 2, and 
Chloramine-T in ethyl alcohol was refluxed on a water bath conditions for 2-3 hours. The progress of the 
reaction was monitored by TLC. After the completion of the reaction and usual work up, the reaction gave the 






Minimum inhibitory concentrations (MICs) of the synthesised compounds 3a-g against different fungal 
and bacterial strains were determined by broth dilution technique.13-14 
 
General procedure for cycloaddition: 
A mixture of oxime 2 (2.2 mmol), ethyl oleate 1 (2.0 mmol) and chloramine-T trihydrate (3.0 mmol) in 
ethyl alcohol (30 ml) was refluxed on water bath for 3 hours. The progress of the reaction was monitored by 
TLC. After the completion of the reaction, the sodium chloride formed was filtered off, and the filtrate was 
evaporated in vacuo. The residual mass was extracted into ether (30 mL), washed successively with water (2 X 
20 mL), 10% sodium hydroxide (2 X 20 mL) and saturated brine solution (1 X 15 mL). The organic layer was 
dried over anhydrous sodium sulphate and the solvent was evaporated to dryness to get the cycloadducts. The 
products were purified by column chromatography using hexane: ethyl acetate (9:2 v/v) as eluent. 
 
Results and Discussion: 
Chemistry: 
 
The general synthetic pathway employed is depicted in the scheme-1.  
Ethyl 8-(4-octyl-3-phenyl-4,5-dihydroisoxazol-5-yl)octanoate 3a: Obtained from ethyl oleate 1 (2.0 mmol) and 
benzaldehyde oxime 2 (2.2 mmol), as light yellow oil in 68% yield. 1H NMR (CDCl3): δ 0.88 (q, 3H, CH3), 1.02 
(t, 3H, CH3), 1.24-1.48 (m, 14H, CH2), 1.88-1.94 (m, 8H, CH2), 2.22-2.28 (m, 4H, CH2), 3.60 (t, 2H, COCH2), 
3.98-4.00 (q, 2H, OCH2), 4.14 (d, 1H, J=8.6Hz, C4-H), 5.20 (d, 1H, J=8.2Hz, C5-H), 7.50-7.72 (m, 5H, Ar-H). 
MS (relative abundance) m/z: 430 (M+1, 24), 429 (M+, 33), 400 (16), 311 (M-118, 100), 297 (34), 265 (54), 247 
(20). Anal. Calcd. for C27H43NO3, C, 75.48; H, 10.09; N, 3.26%; Found: C, 75.40; H, 10.01; N, 3.30%.  
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Ethyl 8-(3-(4-methoxyphenyl)-4-octyl-4,5-dihydroisoxazol-5-yl)octanoate 3b: Obtained from ethyl oleate 1 
(2.0 mmol) and 4-methoxybenzaldehyde oxime 2 (2.2 mmol), as a light yellow oil in 66% yield. 1H NMR 
(CDCl3): δ 0.86 (q, 3H, CH3), 1.08 (t, 3H, CH3), 1.16-1.46 (m, 14H, CH2), 1.88-1.93 (m, 8H, CH2), 2.20-2.30 
(m, 4H, CH2), 3.64 (t, 2H, COCH2), 3.86 (s, 3H, OCH3), 3.98-4.02 (q, 2H, OCH2), 4.16 (d, 1H, J=8.8Hz, C4-H), 
5.18 (d, 1H, J=9.0Hz, C5-H), 7.20 (dd, 2H, Ar-H), 7.56 (dd, 2H, Ar-H). MS (relative abundance) m/z: 460 
(M+1, 16), 459 (M+, 26), 429 (26), 444 (22), 311 (M-148, 100), 297 (30), 265 (50), 247 (26). Anal. Calcd. for 
C28H45NO4, C, 73.16; H, 9.87; N, 3.05%; Found: C, 73.20; H, 9.98; N, 3.00%. 
 
Ethyl 8-(3-(3,4-dimethoxyphenyl)-4-octyl-4,5-dihydroisoxazol-5-yl)octanoate 3c: Obtained from ethyl oleate 1 
(2.0 mmol) and 3,4-dimethoxybenzaldehyde oxime 2 (2.2 mmol), as a pale yellow oil in 78% yield. 1H NMR 
(CDCl3): δ 0.84 (q, 3H, CH3), 1.05 (t, 3H, CH3), 1.20-1.48 (m, 14H, CH2), 1.86-1.92 (m, 8H, CH2), 2.16-2.24 
(m, 4H, CH2), 3.64 (t, 2H, COCH2), 3.85 (s, 6H, OCH3), 3.94-4.00 (q, 2H, OCH2), 4.06 (d, 1H, J=8.0Hz, C4-H), 
5.26 (d, 1H, J=8.8Hz, C5-H), 6.98-7.28 (m, 3H, Ar-H). Anal. Calcd. for C29H47NO5, C, 71.13; H, 9.67; N, 
2.86%; Found: C, 71.18; H, 9.60; N, 2.89%. 
 
Ethyl 8-(3-(4-methylphenyl)-4-octyl-4,5-dihydroisoxazol-5-yl)octanoate 3d: Obtained from ethyl oleate 1 (2.0 
mmol) and 4-methylbenzaldehyde oxime 2 (2.2 mmol), as a viscous mass in 72% yield. 1H NMR (CDCl3): δ 
0.82 (q, 3H, CH3), 1.12 (t, 3H, CH3), 1.21-1.46 (m, 14H, CH2), 1.90-1.92 (m, 8H, CH2), 2.18-2.32 (m, 4H, 
CH2), 2.44 (s, 3H, CH3), 3.60 (t, 2H, COCH2), 3.96-4.00 (q, 2H, OCH2), 4.08 (d, 1H, J=8.6Hz, C4-H), 5.20 (d, 
1H, J=8.0Hz, C5-H), 7.24 (dd, 2H, Ar-H), 7.62 (dd, 2H, Ar-H). Anal. Calcd. for C28H45NO23, C, 75.80; H, 
10.22; N, 3.16%; Found: C, 75.88; H, 10.20; N, 3.10%. 
 
Ethyl 8-(3-(4-fluorophenyl)-4-octyl-4,5-dihydroisoxazol-5-yl)octanoate 3e: Obtained from ethyl oleate 1 (2.0 
mmol) and 4-fluorobenzaldehyde oxime 2 (2.2 mmol), as a colourless oil in 70% yield. 1H NMR (CDCl3): δ 
0.78 (q, 3H, CH3), 1.15 (t, 3H, CH3), 1.20-1.52 (m, 14H, CH2), 1.91-1.93 (m, 8H, CH2), 2.20-2.32 (m, 4H, 
CH2), 3.62 (t, 2H, COCH2), 3.96-4.01(q, 2H, OCH2), 4.05 (d, 1H, J=8.0Hz, C4-H), 5.25 (d, 1H, J=8.2Hz, C5-
H), 7.21 (dd, 2H, Ar-H), 7.65 (dd, 2H, Ar-H). MS (relative abundance) m/z: 448 (M+1, 24), 447 (M+, 12), 446 
(M-1, 28), 432 (22), 311 (M-135, 100), 297 (20), 265 (58), 247 (20). Anal. Calcd. for C27H42FNO3, C, 72.45; H, 
9.46; N, 3.13%; Found: C, 72.36; H, 9.31; N, 3.18%. 
 
Ethyl 8-(3-(4-chlorophenyl)-4-octyl-4,5-dihydroisoxazol-5-yl)octanoate 3f: Obtained from ethyl oleate 1 (2.0 
mmol) and 4-chlorobenzaldehyde oxime 2 (2.2 mmol), as a colorless oil in 80% yield. 1H NMR (CDCl3): δ 0.81 
(q, 3H, CH3), 1.12 (t, 3H, CH3), 1.22-1.48 (m, 14H, CH2), 1.90-1.94 (m, 8H, CH2), 2.21-2.34 (m, 4H, CH2), 
3.60 (t, 2H, COCH2), 3.96-4.03 (q, 2H, OCH2), 4.14 (d, 1H, J=7.8Hz, C4-H), 5.21 (d, 1H, J=8.6Hz, C5-H), 7.25 
(dd, 2H, Ar-H), 7.61 (dd, 2H, Ar-H). MS (relative abundance) m/z: 465 (M+, 37Cl, 20), 463 (M+, 35Cl, 60), 448 
(20), 311 (M-152, 100), 297 (28), 265 (62), 247 (18). Anal. Calcd. for C27H42ClNO3, C, 69.88; H, 9.12; N, 
3.02%; Found: C, 69.76; H, 9.01; N, 3.12%. 
 
Ethyl 8-(3-(4-nitrophenyl)-4-octyl-4,5-dihydroisoxazol-5-yl)octanoate 3g: Obtained from ethyl oleate 1 (2.0 
mmol) and 4-nitrobenzaldehyde oxime 2 (2.2 mmol), as a light yellow oil in 69% yield. 1H NMR (CDCl3): δ 
0.88 (q, 3H, CH3), 1.10 (t, 3H, CH3), 1.18-1.49 (m, 14H, CH2), 1.93-1.96 (m, 8H, CH2), 2.16-2.30 (m, 4H, 
CH2), 3.68 (t, 2H, COCH2), 3.99-4.03 (q, 2H, OCH2), 4.08 (d, 1H, J=7.7Hz, C4-H), 5.28 (d, 1H, J=8.3Hz, C5-
H), 8.01 (dd, 2H, Ar-H), 8.28 (dd, 2H, Ar-H). Anal. Calcd. for C27H42N2O5, C, 68.32; H, 8.92; N, 5.90%; 
Found: C, 68.21; H, 8.86; N, 5.82%. 
 
The structures of the cycloadducts were provided by spectral studies and elemental analysis. For 
instance, in 1H NMR spectra, all cycloadducts 3a-g showed the peaks due to aromatic and substituent protons at 
the expected region. The consistent pattern signals due to C4-H appear as doublet in the region δ 4.05-4.16 
ppm., while signals due to C5-H appears as doublet in the region δ 5.18-5.28 ppm. The coupling constant (J) 
values were in range J=7.7-8.8Hz, and J=8.0-9.0Hz for C4-H and C5-H respectively; these values suggests that 
the reaction leads to form cis products. 
All the synthesised cycloadducts 3a-g gave significantly stable molecular ion peaks with a relative 
abundance ranging from 10-65% and base peak at m/z 311. Further, satisfactorily CHN analysis with a 
deviation of ±0.10% from the theoretically calculated values observed strongly favor the formation of the 
cycloadducts. 
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Antimicrobial activity:  
Antifungal activity: Minimum inhibitory concentrations (MICs) of the synthesised compounds 3a-g were 
determined against fungal species C. neoformans, A. niger, A. flavus and C. albicans. The experiments were 
performed in triplicate; the results are expressed as a mean of three determinations and were summarized in 
Table-1.  
 














*Values are expressed as mean of the three determinations (n=3),  
**Amphotericin B was used as reference standard drug 
 
 
All the synthesised compounds 3a-g exerted a moderate to good in vitro antifungal activity against the 
tested organisms, except 3g that contain a strong electron withdrawing nitro substituent failed to exhibit 
inhibition against all the organisms even at a higher concentration of  200 µg/mL. Similarly, the compounds 3a, 
3e failed to inhibit the growth of A. flavus and C. albicans and 3d failed to inhibit the growth of C. neoformans 
and A. niger organisms. The compound 3f having chloro substitution exhibited remarkable activity against all 
the organisms tested in comparison with the standard, while 3b showed good and the remaining compounds 
exhibited moderate activity. 
 
Antibacterial activity:  
The antibacterial activities of the synthesised compounds 3a-g were determined against Gram-negative bacteria 
species Escherichia coli, Pseudomonas aeruginosa, Gram-positive bacteria species Staphylococcus aureus, 
Streptococcus pyogenes. The experiments were performed in triplicate; the results are expressed as a mean of 
three determinations and were summarized in Table-2.  
 
Table 2: MIC’s of the test compounds 3a-g against different bacteria species 
 
Compound Minimum inhibitory concentration (MIC)* in µg/mL 
 S. aureus S. pyogenes E. coli P. aeruginosa 
3a 50 100 - - 
3b 25 100 100 50 
3c 25 100 100 50 
3d 100 200 100 50 
3e 25 50 50 25 
3f 12.5 25 25 25 
3g - - - - 
Std** 25 50 50 25 
*Values are expressed as mean of the three determinations (n=3),  
**Ciprofloxacin was used as reference standard drug. 
Compound Minimum inhibitory concentration (MIC)* in µg/mL 
 C. neoformans A. niger A. flavus C. albicans 
3a 50 100 - - 
3b 25 50 50 25 
3c 25 100 100 50 
3d - - 200 100 
3e 25 50 - - 
3f 12.5 25 25 25 
3g - - - - 
Std** 25 50 50 25 
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The synthesized compounds 3a-f showed moderate to good antibacterial activity against the organisms 
tested. However, the compound 3g having strong electron withdrawing nitro substitution on the benzene ring 
failed to inhibit the growth against the all species tested even at a higher concentration of 200 µg/mL. The 
compound 3a found inactive against E. coli and P. aeruginosa. The presence of chloro substitution in 
compound 3g influenced it to exhibit inhibition to greater extent against the organisms tested.  
 
Conclusion: 
The use of biomolecule ethyl oleate as one of the precursor in organic synthesis validates the 
significance of this study. The utility of ethyl oleate in the synthesis of novel isoxazolines and their in vitro 
antifungal and antibacterial activity results reveals that the compound ethyl 8-(3-(4-chlorophenyl)-4-octyl-4,5-
dihydroisoxazol-5-yl)octanoate 3f may become an potential antifungal and antibacterial drug.  We believe that 
the insights gained in this study would be useful for the development of potential drug candidates derived from 
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